Irinotecan in Treating Young Patients With Refractory or Recurrent Hepatoblastoma

This study is ongoing, but not recruiting participants.
Sponsor:
Information provided by:
National Cancer Institute (NCI)
ClinicalTrials.gov Identifier:
NCT00287976
First received: February 6, 2006
Last updated: September 16, 2013
Last verified: June 2009
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Study Completion Date: No date given
  Estimated Primary Completion Date: December 2008 (Final data collection date for primary outcome measure)